Been There, Not Done That — Melanoma in the Age of Molecular Therapy — NEJM - http://www.nejm.org/doi...
Jun 5, 2011
from
RT @NEJM: BRIM-3 editorial: Vemurafenib’s availability a defining moment; will have important effect on survival , QOL. #ASCO11 http://b ...
- Sally Church